Increased Nirmatrelvir-Ritonavir Prescriptions Did Not Reduce COVID-19 Hospitalization, Mortality

Retrieved on: 2025-02-28 17:27:10

Tags for this article:

COVID-19 drug development

CYP3A4 inhibitors

Nirmatrelvir/ritonavir

Zoonoses

Carbamates

Treatment and management of COVID-19

Click the tags to see associated articles and topics

Increased Nirmatrelvir-Ritonavir Prescriptions Did Not Reduce COVID-19 Hospitalization, Mortality. View article details on hiswai:

Excerpt

“Randomized clinical trials of nirmatrelvir-ritonavir found reduced COVID-19–related hospitalizations among unvaccinated patients but not vaccinated ...

Article found on: www.drugtopics.com

View Original Article